Day One Biopharmaceuticals (DAWN) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free DAWN Stock Alerts $16.41 -0.67 (-3.92%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDay One Biopharmaceuticals, Inc. Forecasted to Post Q3 2024 Earnings of ($0.69) Per Share (NASDAQ:DAWN)marketbeat.com - May 9 at 7:13 AMTimesSquare Capital Management LLC Has $24.33 Million Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)marketbeat.com - May 9 at 12:57 AMDay One Biopharmaceuticals (NASDAQ:DAWN) Given "Outperform" Rating at Wedbushamericanbankingnews.com - May 8 at 6:24 AMDay One Biopharmaceuticals (NASDAQ:DAWN) Given "Buy" Rating at Needham & Company LLCamericanbankingnews.com - May 8 at 5:52 AMDay One Biopharmaceuticals (NASDAQ:DAWN) Given New $40.00 Price Target at HC Wainwrightamericanbankingnews.com - May 8 at 5:52 AMBuy Rating for Day One Biopharmaceuticals Amidst DAY101 Approval and Strong Market Entrymarkets.businessinsider.com - May 8 at 1:18 AMBuy Rating on Day One Biopharmaceuticals: Ojemda’s Market Potential and Strategic Commercializationmarkets.businessinsider.com - May 8 at 1:18 AMDay One Biopharmaceuticals (NASDAQ:DAWN) Given Outperform Rating at Wedbushmarketbeat.com - May 7 at 3:06 PMDay One Biopharmaceuticals, Inc.: Day One Reports First Quarter 2024 Financial Results and Corporate Progressfinanznachrichten.de - May 7 at 10:16 AMIndegene IPO subscribed 7.34 times on Day 2msn.com - May 7 at 10:16 AMHC Wainwright Lowers Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target to $40.00marketbeat.com - May 7 at 8:32 AMDay One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Down Following Insider Sellingamericanbankingnews.com - May 7 at 1:34 AMDay One Reports First Quarter 2024 Financial Results and Corporate Progressglobenewswire.com - May 6 at 4:30 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Down on Insider Sellingmarketbeat.com - May 6 at 10:36 AMJeremy Bender Sells 9,154 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stockamericanbankingnews.com - May 5 at 6:50 AMCharles N. York II Sells 8,078 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stockamericanbankingnews.com - May 5 at 5:42 AMCharles N. York II Sells 52,183 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stockamericanbankingnews.com - May 5 at 5:10 AMJeremy Bender Sells 70,051 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stockamericanbankingnews.com - May 5 at 4:38 AMDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) CFO Charles N. York II Sells 8,078 Sharesinsidertrades.com - May 4 at 8:09 AMInsider Sale at Day One Biopharmaceuticals Inc (DAWN)finance.yahoo.com - May 4 at 4:22 AMDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) CFO Sells $144,192.30 in Stockmarketbeat.com - May 3 at 9:03 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 52-Week High at $17.87marketbeat.com - May 1 at 3:50 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Trading 5.2% Higher marketbeat.com - April 29 at 1:56 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 10.9%marketbeat.com - April 25 at 6:17 PMDay One slips despite Ojemda approval as BofA says label “not a home run”msn.com - April 24 at 7:17 PMDay One Pharmaceuticals: Ojemda Approval A Big Win, Current Valuation Fairseekingalpha.com - April 24 at 2:15 PMDay One Biopharmaceuticals' (DAWN) "Outperform" Rating Reiterated at Wedbushmarketbeat.com - April 24 at 2:13 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Sees Large Volume Increase Following Analyst Upgrademarketbeat.com - April 24 at 11:01 AMDay One Biopharmaceuticals (NASDAQ:DAWN) Price Target Raised to $33.00 at Needham & Company LLCmarketbeat.com - April 24 at 7:29 AMBuy Rating on Day One Biopharmaceuticals Amid FDA Approval and Strong Market Prospectsmarkets.businessinsider.com - April 23 at 11:13 PMBuy Rating Affirmed for Day One Biopharmaceuticals Following FDA Approval of Ojemdamarkets.businessinsider.com - April 23 at 11:13 PMDay One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumorfinance.yahoo.com - April 23 at 6:12 PMDay One's OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumorglobenewswire.com - April 23 at 3:56 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Trading Up 12.2% on Analyst Upgrademarketbeat.com - April 23 at 2:37 PMDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Insider Samuel C. Blackman Sells 10,000 Sharesinsidertrades.com - April 23 at 4:24 AMBuy Rating Affirmed for Day One Biopharmaceuticals on Strong Tovorafenib Prospects and Market Impactmarkets.businessinsider.com - April 22 at 10:07 PMInsider Selling: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Insider Sells 10,000 Shares of Stockmarketbeat.com - April 22 at 9:20 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up Following Analyst Upgrademarketbeat.com - April 22 at 11:39 AMDay One Biopharmaceuticals (NASDAQ:DAWN) PT Raised to $36.00 at JPMorgan Chase & Co.marketbeat.com - April 22 at 11:00 AMDay One Biopharmaceuticals (NASDAQ:DAWN) Shares Down 4.7% marketbeat.com - April 19 at 2:56 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Sees Strong Trading Volumemarketbeat.com - April 18 at 4:55 PMAnalysts Are Bullish on These Healthcare Stocks: OptimizeRx (OPRX), Day One Biopharmaceuticals (DAWN)markets.businessinsider.com - April 16 at 6:18 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Trading 3.8% Higher marketbeat.com - April 16 at 2:01 PMDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Short Interest Down 6.6% in Marchmarketbeat.com - April 16 at 1:40 PMBuy Rating on Day One Biopharmaceuticals Ahead of Tovorafenib PDUFA Date and Potential for Market Disruptionmarkets.businessinsider.com - April 10 at 8:30 AMVanguard Group Inc. Grows Stake in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)marketbeat.com - April 8 at 4:09 AMDay One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 3.4%marketbeat.com - April 4 at 5:28 PMDay One Biopharmaceuticals Inc DAWNmorningstar.com - April 4 at 1:27 PMDay One Biopharmaceuticals (NASDAQ:DAWN) Trading 6.9% Higher marketbeat.com - March 28 at 7:27 PMDay One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Insider Sells $160,100.00 in Stockmarketbeat.com - March 26 at 9:17 PM Get Day One Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DAWN and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here DAWN Media Mentions By Week DAWN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DAWN News Sentiment▼-0.040.36▲Average Medical News Sentiment DAWN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DAWN Articles This Week▼313▲DAWN Articles Average Week Get Day One Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for DAWN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kura Oncology News Today Ardelyx News Today Dynavax Technologies News Today Protagonist Therapeutics News Today LeMaitre Vascular News Today Zai Lab News Today ANI Pharmaceuticals News Today Taro Pharmaceutical Industries News Today Arcus Biosciences News Today Akero Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DAWN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Day One Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
